My interpretation of this study is that, although sFLT-1 is elevated in preeclampsia, the elevations may not be found early enough in gestation for a meaningful change in our therapeutic course of action. This, however, is somewhat disputed by another study 2 years later in the AJOG (click here for the study). I’d like to know what others think about this test and its applicability.